HC Wainwright Has Negative Forecast for OLMA Q2 Earnings
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – HC Wainwright cut their Q2 2025 earnings per share estimates for Olema Pharmaceuticals in a report issued on Monday, June 2nd. HC Wainwright analyst E. Bodnar now expects that the company will post earnings of ($0.70) per share for the quarter, down from their prior forecast of […]
